Intercept Pharmaceuticals
Dick Lancaster has worked in the pharmaceutical industry for several years. Dick started their career at Amylin Pharmaceuticals in 2007, where they held multiple roles including Regulatory-CMC Manager, Manager of Regulatory Affairs, and Product Development Manager. In 2011, they joined Intercept Pharmaceuticals as the Vice President of Product Development.
Dick Lancaster attended DePauw University from 1989 to 1993, where they obtained a Bachelor of Science degree in Chemistry. After completing their undergraduate studies, they continued their education at the University of Chicago from 1993 to 1994, earning a Master of Science degree in Organic Chemistry.
This person is not in any offices
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.